Literature DB >> 13680115

Improved survival of critically ill cancer patients with septic shock.

Jérôme Larché1, Elie Azoulay, Fabienne Fieux, Laurent Mesnard, Delphine Moreau, Guillaume Thiery, Michaël Darmon, Jean-Roger Le Gall, Benoît Schlemmer.   

Abstract

OBJECTIVE: To identify predictors of 30-day mortality in critically ill cancer patients with septic shock.
DESIGN: Retrospective study over a 6-year period.
SETTING: Twelve-bed medical intensive care unit (ICU). PATIENTS: Eighty-eight patients (55 men, 33 women) aged 55 (43.5-63) years admitted to the ICU for septic shock.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Eighty (90.9%) patients had hematological malignancies and eight (9.1%) had solid tumors; 47 patients (53.4%) were neutropenic, 19 (21.6%) were hematopoietic stem cell transplantation (HSCT) recipients, and 27 (30.7%) were in remission. Microbiologically documented infections were found in 60 (68.2%) patients. The Simplified Acute Physiologic Score II (SAPS II) and Logistic Organ Dysfunction (LOD) scores at ICU admission were 66 (47-89) and 7 (5-10), respectively, and the LOD score on day 3 was 8 (4-10). Sixty-eight (78.1%) patients received invasive mechanical ventilation (MV), 12 (13.6%) noninvasive MV, 22 (25%) dialysis. Thirty-day mortality was 65.5% (57/88). By multivariable analysis, mortality was higher when time to antibiotic treatment was >2 h [odds ratio (OR), 7.05; 95% confidence interval (95% CI), 1.17-42.21] and when DLOD (day 3-day 1 LOD score/day 3 LOD score) was high (OR, 3.47; 95% CI, 1.44-8.39); mortality was lower when admission occurred between 1998 and 2000 (OR, 0.23; 95% CI, 0.05-0.98) and when initial antibiotics were adapted (OR, 0.24; 95% CI, 0.06-0.09).
CONCLUSIONS: Earlier ICU admission and antibiotic treatment of critically ill cancer patients with septic shock is associated with higher 30-day survival. The LOD score change on day 3 as compared to admission is useful for predicting survival.

Entities:  

Mesh:

Year:  2003        PMID: 13680115     DOI: 10.1007/s00134-003-1957-y

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  35 in total

1.  Earlier initiation of antibiotic treatment for severe infections after interventions to improve the organization and specific guidelines in the emergency department.

Authors:  S Natsch; B J Kullberg; J F Meis; J W van der Meer
Journal:  Arch Intern Med       Date:  2000-05-08

Review 2.  Severe infections after bone marrow transplantation.

Authors:  R A Barnes; N Stallard
Journal:  Curr Opin Crit Care       Date:  2001-10       Impact factor: 3.687

3.  Delay in administering the first dose of antibiotics in patients admitted to hospital with serious infections.

Authors:  S Natsch; B J Kullberg; J W van der Meer; J F Meis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-10       Impact factor: 3.267

4.  Legionnaires' disease after bone marrow transplantation.

Authors:  J Meletis; G Arlet; E Dournon; S Pol; A Devergie; C Sportes; M N Peraldi; C Mayaud; Y Perol; E Gluckman
Journal:  Bone Marrow Transplant       Date:  1987-10       Impact factor: 5.483

5.  Prognostic factors for neutropenic patients in an intensive care unit: respective roles of underlying malignancies and acute organ failures.

Authors:  F Blot; M Guiguet; G Nitenberg; B Leclercq; B Gachot; B Escudier
Journal:  Eur J Cancer       Date:  1997-06       Impact factor: 9.162

6.  Outcomes of critically ill cancer patients in a university hospital setting.

Authors:  J P Kress; J Christenson; A S Pohlman; D R Linkin; J B Hall
Journal:  Am J Respir Crit Care Med       Date:  1999-12       Impact factor: 21.405

7.  Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials.

Authors:  L S Elting; E B Rubenstein; K V Rolston; G P Bodey
Journal:  Clin Infect Dis       Date:  1997-08       Impact factor: 9.079

8.  Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: a case for evidence-based guidelines.

Authors:  G D Rubenfeld; S W Crawford
Journal:  Ann Intern Med       Date:  1996-10-15       Impact factor: 25.391

9.  APACHE-acute physiology and chronic health evaluation: a physiologically based classification system.

Authors:  W A Knaus; J E Zimmerman; D P Wagner; E A Draper; D E Lawrence
Journal:  Crit Care Med       Date:  1981-08       Impact factor: 7.598

10.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

View more
  70 in total

Review 1.  Year in review in Intensive Care Medicine-2003. Part 1: Respiratory failure, infection and sepsis.

Authors:  Edward Abraham; Peter Andrews; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Michael Pinsky; Peter Radermacher; Marco Ranieri; Christian Richard; Robert Tasker; Benoît Vallet
Journal:  Intensive Care Med       Date:  2004-05-15       Impact factor: 17.440

2.  The intensive care support of patients with malignancy: do everything that can be done.

Authors:  Elie Azoulay; Bekele Afessa
Journal:  Intensive Care Med       Date:  2005-11-25       Impact factor: 17.440

Review 3.  Diagnostic strategy in cancer patients with acute respiratory failure.

Authors:  Elie Azoulay; Benoît Schlemmer
Journal:  Intensive Care Med       Date:  2006-04-29       Impact factor: 17.440

4.  Can we still refuse ICU admission of patients with hematological malignancies?

Authors:  Frédéric Pène; Márcio Soares
Journal:  Intensive Care Med       Date:  2008-01-24       Impact factor: 17.440

5.  Antimicrobial susceptibility testing of Gram-positive and -negative bacterial isolates directly from spiked blood culture media with Raman spectroscopy.

Authors:  H E Dekter; C C Orelio; M C Morsink; S Tektas; B Vis; R Te Witt; W B van Leeuwen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-08       Impact factor: 3.267

6.  Critical care management of lung cancer patients to prolong life without prolonging dying.

Authors:  Márcio Soares; Elie Azoulay
Journal:  Intensive Care Med       Date:  2009-09-19       Impact factor: 17.440

7.  Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit.

Authors:  Dominique D Benoit; Pieter O Depuydt; Koenraad H Vandewoude; Fritz C Offner; Tom Boterberg; Carole A De Cock; Lucien A Noens; Ann M Janssens; Johan M Decruyenaere
Journal:  Intensive Care Med       Date:  2005-11-25       Impact factor: 17.440

8.  Early antimicrobial therapy in severe sepsis and septic shock.

Authors:  Anand Kumar
Journal:  Curr Infect Dis Rep       Date:  2010-09       Impact factor: 3.725

9.  Early and adequate antibiotic therapy in the treatment of severe sepsis and septic shock.

Authors:  John D Dickinson; Marin H Kollef
Journal:  Curr Infect Dis Rep       Date:  2011-10       Impact factor: 3.725

10.  Continued survival gains in recent years among critically ill myeloma patients.

Authors:  Vincent Peigne; Katerina Rusinová; Lionel Karlin; Michael Darmon; Jean-Paul Fermand; Benoît Schlemmer; Elie Azoulay
Journal:  Intensive Care Med       Date:  2008-10-14       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.